Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Sinopharm

Ex-Sinopharm Manager Caught in Anti-Graft Dragnet

China’s corruption investigators are looking into Zhou Bin, a former deputy general manager of the state-owned drugmaker, for ‘serious violations of discipline and law’

Caixin Global · Feb 2, 2024

COVID-19 Booster Shot: Study Says Half Dose Of Pfizer Vaccine Produces Strong Immune Response

The team discovered that people who previously received AstraZeneca or Sinopharm COVID-19 vaccines had a "non-inferior" immune response when given a half dose of a Pfizer COVID-19 booster vaccine, comparable to those who received a full dose.

Medical Daily · Nov 27, 2023

China finally approves an mRNA COVID vaccine—but only for some foreigners

Beijing's uneasy relationship with mRNA vaccines is all the more relevant as it begins to relax COVID restrictions.

Fortune · Dec 12, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Fauci: China's less-effective vaccines are stopping it from exiting COVID-zero

But a bigger problem for Beijing may be the number of elderly Chinese who have yet to get their booster shots.

Fortune · Dec 2, 2022

Some Omicron sub-variants escaping antibodies from Sinopharm shot -Chinese study

A small Chinese study detailed in The Lancet Infectious Diseases journal showed neutralising antibodies against some Omicron sub-variants were largely undetectable after two doses of a Sinopharm COVID-19 vaccine, with a booster shot only partly restoring them.

Reuters · Jun 21, 2022

ChromaDex Establishes Joint Venture For Tru Niagen Distribution In China

ChromaDex Corp (NASDAQ:CDXC) has agreed to establish a joint venture through its wholly-owned subsidiary ChromaDex Asia Limited. ChromaDex Asia is expected to assume the distribution agreement with Sinopharm Xingsha relating to the commercialization of Tru Niagen in mainland China and its territories, excluding Hong Kong, Macau, and Taiwan. Also See: ChromaDex Shares Gain On Niagen Supply Pact With…

Benzinga · May 20, 2022

Chinese Omicron-specific mRNA COVID vaccine candidate to be trialed in UAE

China's Suzhou Abogen Biosciences Co said its COVID-19 vaccine candidate using the messenger RNA (mRNA) technology and targeting the Omicron variant has obtained clinical trial approval in the United Arab Emirates.

Reuters · Apr 30, 2022

Read news from The Economist, FT, and more,
with one subscription

Sinopharm testing Omicron vaccine

BEIJING: The Chinese drugmaker Sinopharm says a subsidiary has received approval for clinical trials of a new vaccine specifically to target the Omicron coronavirus variant.

Bangkok Post · Apr 16, 2022

Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial

COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong, the companies said on Saturday.

Reuters · Apr 16, 2022

COVID: China is developing its own mRNA vaccine – and it's showing early promise

China, the country that first detected the novel coronavirus, remains one of the few not to have imported one of the exceptionally effective mRNA COVID vaccines developed by Pfizer and Moderna. Instead, it has so far relied on vaccines developed by two Chinese companies, Sinovac and Sinopharm. However, this may…

The Conversation · Feb 15, 2022

Coverage From

People

Anthony Fauci

718 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.